Global Xenotransplantation Market Research Report 2023

Xenotransplantation Market

The global Xenotransplantation market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Xenotransplantation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Xenotransplantation is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Xenotransplantation in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Xenotransplantation include Sino-Clone Organ Biotechnology, Qihan Biotech, Grand Life Science & Technology, Geneo, Terumo Medical Corporation, Transonic, Roche, Astellas Pharma and Preservation Solutions, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Xenotransplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Xenotransplantation.

The Xenotransplantation market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Xenotransplantation market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Xenotransplantation companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Xenotransplantation Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Xenotransplantation Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Organ Preservation Solutions

1.2.3 Transplant Diagnostics

1.2.4 Tissue Products

1.3 Market by Application

1.3.1 Global Xenotransplantation Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Transplant Center

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Xenotransplantation Market Perspective (2018-2029)

2.2 Xenotransplantation Growth Trends by Region

2.2.1 Global Xenotransplantation Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Xenotransplantation Historic Market Size by Region (2018-2023)

2.2.3 Xenotransplantation Forecasted Market Size by Region (2024-2029)

2.3 Xenotransplantation Market Dynamics

2.3.1 Xenotransplantation Industry Trends

2.3.2 Xenotransplantation Market Drivers

2.3.3 Xenotransplantation Market Challenges

2.3.4 Xenotransplantation Market Restraints

3.1 Global Top Xenotransplantation Players by Revenue

3.1.1 Global Top Xenotransplantation Players by Revenue (2018-2023)

3.1.2 Global Xenotransplantation Revenue Market Share by Players (2018-2023)

3.2 Global Xenotransplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Xenotransplantation Revenue

3.4 Global Xenotransplantation Market Concentration Ratio

3.4.1 Global Xenotransplantation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Xenotransplantation Revenue in 2022

3.5 Xenotransplantation Key Players Head office and Area Served

3.6 Key Players Xenotransplantation Product Solution and Service

3.7 Date of Enter into Xenotransplantation Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Xenotransplantation Historic Market Size by Type (2018-2023)

4.2 Global Xenotransplantation Forecasted Market Size by Type (2024-2029)

5.1 Global Xenotransplantation Historic Market Size by Application (2018-2023)

5.2 Global Xenotransplantation Forecasted Market Size by Application (2024-2029)

6.1 North America Xenotransplantation Market Size (2018-2029)

6.2 North America Xenotransplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Xenotransplantation Market Size by Country (2018-2023)

6.4 North America Xenotransplantation Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Xenotransplantation Market Size (2018-2029)

7.2 Europe Xenotransplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Xenotransplantation Market Size by Country (2018-2023)

7.4 Europe Xenotransplantation Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Xenotransplantation Market Size (2018-2029)

8.2 Asia-Pacific Xenotransplantation Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Xenotransplantation Market Size by Region (2018-2023)

8.4 Asia-Pacific Xenotransplantation Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Xenotransplantation Market Size (2018-2029)

9.2 Latin America Xenotransplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Xenotransplantation Market Size by Country (2018-2023)

9.4 Latin America Xenotransplantation Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Xenotransplantation Market Size (2018-2029)

10.2 Middle East & Africa Xenotransplantation Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Xenotransplantation Market Size by Country (2018-2023)

10.4 Middle East & Africa Xenotransplantation Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Sino-Clone Organ Biotechnology

11.1.1 Sino-Clone Organ Biotechnology Company Detail

11.1.2 Sino-Clone Organ Biotechnology Business Overview

11.1.3 Sino-Clone Organ Biotechnology Xenotransplantation Introduction

11.1.4 Sino-Clone Organ Biotechnology Revenue in Xenotransplantation Business (2018-2023)

11.1.5 Sino-Clone Organ Biotechnology Recent Development

11.2 Qihan Biotech

11.2.1 Qihan Biotech Company Detail

11.2.2 Qihan Biotech Business Overview

11.2.3 Qihan Biotech Xenotransplantation Introduction

11.2.4 Qihan Biotech Revenue in Xenotransplantation Business (2018-2023)

11.2.5 Qihan Biotech Recent Development

11.3 Grand Life Science & Technology

11.3.1 Grand Life Science & Technology Company Detail

11.3.2 Grand Life Science & Technology Business Overview

11.3.3 Grand Life Science & Technology Xenotransplantation Introduction

11.3.4 Grand Life Science & Technology Revenue in Xenotransplantation Business (2018-2023)

11.3.5 Grand Life Science & Technology Recent Development

11.4 Geneo

11.4.1 Geneo Company Detail

11.4.2 Geneo Business Overview

11.4.3 Geneo Xenotransplantation Introduction

11.4.4 Geneo Revenue in Xenotransplantation Business (2018-2023)

11.4.5 Geneo Recent Development

11.5 Terumo Medical Corporation

11.5.1 Terumo Medical Corporation Company Detail

11.5.2 Terumo Medical Corporation Business Overview

11.5.3 Terumo Medical Corporation Xenotransplantation Introduction

11.5.4 Terumo Medical Corporation Revenue in Xenotransplantation Business (2018-2023)

11.5.5 Terumo Medical Corporation Recent Development

11.6 Transonic

11.6.1 Transonic Company Detail

11.6.2 Transonic Business Overview

11.6.3 Transonic Xenotransplantation Introduction

11.6.4 Transonic Revenue in Xenotransplantation Business (2018-2023)

11.6.5 Transonic Recent Development

11.7 Roche

11.7.1 Roche Company Detail

11.7.2 Roche Business Overview

11.7.3 Roche Xenotransplantation Introduction

11.7.4 Roche Revenue in Xenotransplantation Business (2018-2023)

11.7.5 Roche Recent Development

11.8 Astellas Pharma

11.8.1 Astellas Pharma Company Detail

11.8.2 Astellas Pharma Business Overview

11.8.3 Astellas Pharma Xenotransplantation Introduction

11.8.4 Astellas Pharma Revenue in Xenotransplantation Business (2018-2023)

11.8.5 Astellas Pharma Recent Development

11.9 Preservation Solutions

11.9.1 Preservation Solutions Company Detail

11.9.2 Preservation Solutions Business Overview

11.9.3 Preservation Solutions Xenotransplantation Introduction

11.9.4 Preservation Solutions Revenue in Xenotransplantation Business (2018-2023)

11.9.5 Preservation Solutions Recent Development

11.10 OrganOX Limited

11.10.1 OrganOX Limited Company Detail

11.10.2 OrganOX Limited Business Overview

11.10.3 OrganOX Limited Xenotransplantation Introduction

11.10.4 OrganOX Limited Revenue in Xenotransplantation Business (2018-2023)

11.10.5 OrganOX Limited Recent Development

11.11 Bio-Med (P) Limited

11.11.1 Bio-Med (P) Limited Company Detail

11.11.2 Bio-Med (P) Limited Business Overview

11.11.3 Bio-Med (P) Limited Xenotransplantation Introduction

11.11.4 Bio-Med (P) Limited Revenue in Xenotransplantation Business (2018-2023)

11.11.5 Bio-Med (P) Limited Recent Development

11.12 TransMedic

11.12.1 TransMedic Company Detail

11.12.2 TransMedic Business Overview

11.12.3 TransMedic Xenotransplantation Introduction

11.12.4 TransMedic Revenue in Xenotransplantation Business (2018-2023)

11.12.5 TransMedic Recent Development

11.13 Novartis AG

11.13.1 Novartis AG Company Detail

11.13.2 Novartis AG Business Overview

11.13.3 Novartis AG Xenotransplantation Introduction

11.13.4 Novartis AG Revenue in Xenotransplantation Business (2018-2023)

11.13.5 Novartis AG Recent Development

11.14 Organ Recovery Systems

11.14.1 Organ Recovery Systems Company Detail

11.14.2 Organ Recovery Systems Business Overview

11.14.3 Organ Recovery Systems Xenotransplantation Introduction

11.14.4 Organ Recovery Systems Revenue in Xenotransplantation Business (2018-2023)

11.14.5 Organ Recovery Systems Recent Development

11.15 Accord Healthcare

11.15.1 Accord Healthcare Company Detail

11.15.2 Accord Healthcare Business Overview

11.15.3 Accord Healthcare Xenotransplantation Introduction

11.15.4 Accord Healthcare Revenue in Xenotransplantation Business (2018-2023)

11.15.5 Accord Healthcare Recent Development

11.16 Pfizer

11.16.1 Pfizer Company Detail

11.16.2 Pfizer Business Overview

11.16.3 Pfizer Xenotransplantation Introduction

11.16.4 Pfizer Revenue in Xenotransplantation Business (2018-2023)

11.16.5 Pfizer Recent Development

11.17 Veloxis Pharmaceuticals

11.17.1 Veloxis Pharmaceuticals Company Detail

11.17.2 Veloxis Pharmaceuticals Business Overview

11.17.3 Veloxis Pharmaceuticals Xenotransplantation Introduction

11.17.4 Veloxis Pharmaceuticals Revenue in Xenotransplantation Business (2018-2023)

11.17.5 Veloxis Pharmaceuticals Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Xenotransplantation Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Organ Preservation Solutions

    Table 3. Key Players of Transplant Diagnostics

    Table 4. Key Players of Tissue Products

    Table 5. Global Xenotransplantation Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Xenotransplantation Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Xenotransplantation Market Size by Region (2018-2023) & (US$ Million)

    Table 8. Global Xenotransplantation Market Share by Region (2018-2023)

    Table 9. Global Xenotransplantation Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 10. Global Xenotransplantation Market Share by Region (2024-2029)

    Table 11. Xenotransplantation Market Trends

    Table 12. Xenotransplantation Market Drivers

    Table 13. Xenotransplantation Market Challenges

    Table 14. Xenotransplantation Market Restraints

    Table 15. Global Xenotransplantation Revenue by Players (2018-2023) & (US$ Million)

    Table 16. Global Xenotransplantation Market Share by Players (2018-2023)

    Table 17. Global Top Xenotransplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Xenotransplantation as of 2022)

    Table 18. Ranking of Global Top Xenotransplantation Companies by Revenue (US$ Million) in 2022

    Table 19. Global 5 Largest Players Market Share by Xenotransplantation Revenue (CR5 and HHI) & (2018-2023)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Xenotransplantation Product Solution and Service

    Table 22. Date of Enter into Xenotransplantation Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Xenotransplantation Market Size by Type (2018-2023) & (US$ Million)

    Table 25. Global Xenotransplantation Revenue Market Share by Type (2018-2023)

    Table 26. Global Xenotransplantation Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 27. Global Xenotransplantation Revenue Market Share by Type (2024-2029)

    Table 28. Global Xenotransplantation Market Size by Application (2018-2023) & (US$ Million)

    Table 29. Global Xenotransplantation Revenue Market Share by Application (2018-2023)

    Table 30. Global Xenotransplantation Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 31. Global Xenotransplantation Revenue Market Share by Application (2024-2029)

    Table 32. North America Xenotransplantation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 33. North America Xenotransplantation Market Size by Country (2018-2023) & (US$ Million)

    Table 34. North America Xenotransplantation Market Size by Country (2024-2029) & (US$ Million)

    Table 35. Europe Xenotransplantation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 36. Europe Xenotransplantation Market Size by Country (2018-2023) & (US$ Million)

    Table 37. Europe Xenotransplantation Market Size by Country (2024-2029) & (US$ Million)

    Table 38. Asia-Pacific Xenotransplantation Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 39. Asia-Pacific Xenotransplantation Market Size by Region (2018-2023) & (US$ Million)

    Table 40. Asia-Pacific Xenotransplantation Market Size by Region (2024-2029) & (US$ Million)

    Table 41. Latin America Xenotransplantation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 42. Latin America Xenotransplantation Market Size by Country (2018-2023) & (US$ Million)

    Table 43. Latin America Xenotransplantation Market Size by Country (2024-2029) & (US$ Million)

    Table 44. Middle East & Africa Xenotransplantation Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 45. Middle East & Africa Xenotransplantation Market Size by Country (2018-2023) & (US$ Million)

    Table 46. Middle East & Africa Xenotransplantation Market Size by Country (2024-2029) & (US$ Million)

    Table 47. Sino-Clone Organ Biotechnology Company Detail

    Table 48. Sino-Clone Organ Biotechnology Business Overview

    Table 49. Sino-Clone Organ Biotechnology Xenotransplantation Product

    Table 50. Sino-Clone Organ Biotechnology Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 51. Sino-Clone Organ Biotechnology Recent Development

    Table 52. Qihan Biotech Company Detail

    Table 53. Qihan Biotech Business Overview

    Table 54. Qihan Biotech Xenotransplantation Product

    Table 55. Qihan Biotech Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 56. Qihan Biotech Recent Development

    Table 57. Grand Life Science & Technology Company Detail

    Table 58. Grand Life Science & Technology Business Overview

    Table 59. Grand Life Science & Technology Xenotransplantation Product

    Table 60. Grand Life Science & Technology Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 61. Grand Life Science & Technology Recent Development

    Table 62. Geneo Company Detail

    Table 63. Geneo Business Overview

    Table 64. Geneo Xenotransplantation Product

    Table 65. Geneo Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 66. Geneo Recent Development

    Table 67. Terumo Medical Corporation Company Detail

    Table 68. Terumo Medical Corporation Business Overview

    Table 69. Terumo Medical Corporation Xenotransplantation Product

    Table 70. Terumo Medical Corporation Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 71. Terumo Medical Corporation Recent Development

    Table 72. Transonic Company Detail

    Table 73. Transonic Business Overview

    Table 74. Transonic Xenotransplantation Product

    Table 75. Transonic Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 76. Transonic Recent Development

    Table 77. Roche Company Detail

    Table 78. Roche Business Overview

    Table 79. Roche Xenotransplantation Product

    Table 80. Roche Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 81. Roche Recent Development

    Table 82. Astellas Pharma Company Detail

    Table 83. Astellas Pharma Business Overview

    Table 84. Astellas Pharma Xenotransplantation Product

    Table 85. Astellas Pharma Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 86. Astellas Pharma Recent Development

    Table 87. Preservation Solutions Company Detail

    Table 88. Preservation Solutions Business Overview

    Table 89. Preservation Solutions Xenotransplantation Product

    Table 90. Preservation Solutions Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 91. Preservation Solutions Recent Development

    Table 92. OrganOX Limited Company Detail

    Table 93. OrganOX Limited Business Overview

    Table 94. OrganOX Limited Xenotransplantation Product

    Table 95. OrganOX Limited Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 96. OrganOX Limited Recent Development

    Table 97. Bio-Med (P) Limited Company Detail

    Table 98. Bio-Med (P) Limited Business Overview

    Table 99. Bio-Med (P) Limited Xenotransplantation Product

    Table 100. Bio-Med (P) Limited Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 101. Bio-Med (P) Limited Recent Development

    Table 102. TransMedic Company Detail

    Table 103. TransMedic Business Overview

    Table 104. TransMedic Xenotransplantation Product

    Table 105. TransMedic Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 106. TransMedic Recent Development

    Table 107. Novartis AG Company Detail

    Table 108. Novartis AG Business Overview

    Table 109. Novartis AG Xenotransplantation Product

    Table 110. Novartis AG Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 111. Novartis AG Recent Development

    Table 112. Organ Recovery Systems Company Detail

    Table 113. Organ Recovery Systems Business Overview

    Table 114. Organ Recovery Systems Xenotransplantation Product

    Table 115. Organ Recovery Systems Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 116. Organ Recovery Systems Recent Development

    Table 117. Accord Healthcare Company Detail

    Table 118. Accord Healthcare Business Overview

    Table 119. Accord Healthcare Xenotransplantation Product

    Table 120. Accord Healthcare Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 121. Accord Healthcare Recent Development

    Table 122. Pfizer Company Detail

    Table 123. Pfizer Business Overview

    Table 124. Pfizer Xenotransplantation Product

    Table 125. Pfizer Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 126. Pfizer Recent Development

    Table 127. Veloxis Pharmaceuticals Company Detail

    Table 128. Veloxis Pharmaceuticals Business Overview

    Table 129. Veloxis Pharmaceuticals Xenotransplantation Product

    Table 130. Veloxis Pharmaceuticals Revenue in Xenotransplantation Business (2018-2023) & (US$ Million)

    Table 131. Veloxis Pharmaceuticals Recent Development

    Table 132. Research Programs/Design for This Report

    Table 133. Key Data Information from Secondary Sources

    Table 134. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Xenotransplantation Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Xenotransplantation Market Share by Type: 2022 VS 2029

    Figure 3. Organ Preservation Solutions Features

    Figure 4. Transplant Diagnostics Features

    Figure 5. Tissue Products Features

    Figure 6. Global Xenotransplantation Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Xenotransplantation Market Share by Application: 2022 VS 2029

    Figure 8. Hospital Case Studies

    Figure 9. Transplant Center Case Studies

    Figure 10. Other Case Studies

    Figure 11. Xenotransplantation Report Years Considered

    Figure 12. Global Xenotransplantation Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 13. Global Xenotransplantation Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Xenotransplantation Market Share by Region: 2022 VS 2029

    Figure 15. Global Xenotransplantation Market Share by Players in 2022

    Figure 16. Global Top Xenotransplantation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Xenotransplantation as of 2022)

    Figure 17. The Top 10 and 5 Players Market Share by Xenotransplantation Revenue in 2022

    Figure 18. North America Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 19. North America Xenotransplantation Market Share by Country (2018-2029)

    Figure 20. United States Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. Canada Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Europe Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Xenotransplantation Market Share by Country (2018-2029)

    Figure 24. Germany Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. France Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. U.K. Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Italy Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Russia Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Nordic Countries Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Asia-Pacific Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Xenotransplantation Market Share by Region (2018-2029)

    Figure 32. China Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Japan Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. South Korea Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Southeast Asia Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. India Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Australia Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Latin America Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Xenotransplantation Market Share by Country (2018-2029)

    Figure 40. Mexico Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Brazil Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Middle East & Africa Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Xenotransplantation Market Share by Country (2018-2029)

    Figure 44. Turkey Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Saudi Arabia Xenotransplantation Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Sino-Clone Organ Biotechnology Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 47. Qihan Biotech Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 48. Grand Life Science & Technology Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 49. Geneo Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 50. Terumo Medical Corporation Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 51. Transonic Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 52. Roche Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 53. Astellas Pharma Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 54. Preservation Solutions Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 55. OrganOX Limited Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 56. Bio-Med (P) Limited Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 57. TransMedic Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 58. Novartis AG Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 59. Organ Recovery Systems Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 60. Accord Healthcare Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 61. Pfizer Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 62. Veloxis Pharmaceuticals Revenue Growth Rate in Xenotransplantation Business (2018-2023)

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed